|
| |
|
Table |
|
Neonatal Exendin-4 Prevents the Development of Diabetes in the
Intrauterine Growth Retarded Rat |
|
Volume 19,
Issue 4, 2003 |
|
|
|
|
Body
weight at 2 weeks and 3 months |
| |
|
Treatment group |
2 weeks (g) |
3 months (g) |
|
|
(n=9) |
(n=7) |
|
Control vehicle |
27.7 ± 0.3 |
331.7 ± 7.0 |
|
Control Ex-4 |
22.2 ± 0.6* |
305.3 ± 12.7* |
|
IUGR Ex-4 |
13.8 ± 0.7† |
311.0 ± 4.0† |
|
IUGR vehicle |
17.2 ± 0.7‡ |
351.7 ± 26.2‡ |
|
| |
|
Data are
means ± SE. *P < 0.05 control Ex-4 vs. control vehicle; †P < 0.05 IUGR
Ex-4 vs. IUGR vehicle; ‡P < 0.05 control vehicle vs. IUGR vehicle. |
| |
|
Adapted from
Stoffers DA, et al. Diabetes 2003;52:734-740. |
| |
| |
| |
| |
| |
| |
|
Back to article |
|
|
|
|
|
|
|
|
|
|
